News Sentiment

COAG sentiment intelligence

Hemab Therapeutics Holdings, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 52 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 38.03 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 6

high-authority source matches

Trend context Trend inactive

+22.7% over one week, +52.2% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Negative

Hemab Therapeutics (NASDAQ:COAG) Trading Down 3.8% - Should You Sell?

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction 22.7% Price confirming higher
Trend fit Trend inactive 52.2% over four weeks
Fair value 29.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 36
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Market source 7
MarketBeat 5
GlobeNewswire 5
Stock Titan 5
Seeking Alpha 3
TradingView 3
Moomoo 2
MT Newswires 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 15
Analyst action 6
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 52